Inositol Treatment in Different Type of PCOS Phenotype

Not Applicable

Completed

• Conditions: Polycystic Ovary Syndrome
• Interventions: Dietary Supplement: Myo-inositol

• Registration Number: NCT05678114
• Lead Sponsor: Lo.Li.Pharma s.r.l

Brief Summary

Evaluation of the efficacy of inositol treatment in women with PCOS in relation to the phenotype (according to the Rotterdam Criteria)

Detailed Description

Not available

Study Timeline

• Study Start: 2022-12-21
• Study First Submitted: 2022-12-21
• Study First Submitted QC: 2023-01-09
• Study First Posted: 2023-01-10
• Primary Completion: 2023-04-28
• Status Verified: 2023-05
• Study Completion: 2023-05-12
• Last Update Submitted: 2023-05-15
• Last Update Posted: 2023-05-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

• women with PCOS of any phenotype

Exclusion Criteria

• hormonal treatment (such as contraceptive pill)
• use of supplements containing myo-inositol
• severe co-morbidities

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Non-hyperandrogenic PCOS	Myo-inositol	-
Hyperandrogenic PCOS	Myo-inositol	-

Primary Outcome Measures

Name	Time	Method
Regularization of the menstrual cycle	Change from baseline number of women with irregular menstrual cycle at 4 months	Number of women with regular/altered menstrual cycle

Trial Locations

Locations (1)

Clinica Alma Res; 🇮🇹 Roma, Italy